lobbying_activities: 1347946

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1347946	bbb63dd0-bc3c-405f-b157-baebef8d0732	Q4	SQUIRE PATTON BOGGS	30906	RANBAXY INC.	2012	fourth_quarter	PHA	S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; H.R. 8, the American Taxpayer Relief Act.	HOUSE OF REPRESENTATIVES,SENATE	180000		0	0	2013-01-20T04:25:12.937000-05:00